Teladoc officer to sell 7,357 shares, $46K

Teladoc Health reports a Rule 144 notice for an officer’s planned sale of 7,357 common shares, partly to cover tax obligations on vested equity.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) discloses a planned sale of its common stock under Rule 144 by officer Kelly M. Bliss. A total of 7,357 shares are planned to be sold through Fidelity Brokerage Services LLC, with an indicated aggregate market value of $46,358.67 as of September 2, 2026.

The shares were acquired on September 1, 2026 through restricted stock vesting as compensation, and the sale includes shares needed to cover a tax obligation arising from settlement of a vested equity award distribution. The notice also lists several prior sales of Teladoc common stock by Kelly M. Bliss during the preceding three months.

Key Figures

Shares planned for sale: 7,357 shares Aggregate market value of planned sale: $46,358.67 Acquisition date of shares: September 1, 2026 +4 more

7 metrics

Shares planned for sale 7,357 shares Common stock to be sold under Rule 144, as of September 2, 2026

Aggregate market value of planned sale $46,358.67 Indicated market value for the 7,357 shares as of September 2, 2026

Acquisition date of shares September 1, 2026 Shares acquired via restricted stock vesting as compensation

Prior sale on June 2, 2026 7,679 shares for $58,567.73 Common stock sold by Kelly M. Bliss during preceding three months

Prior sale on June 29, 2026 2,500 shares for $21,250.00 Common stock sale by Kelly M. Bliss

Prior sale on July 1, 2026 2,500 shares for $22,500.00 Common stock sale by Kelly M. Bliss

Prior sale on July 6, 2026 2,500 shares for $23,750.00 Common stock sale by Kelly M. Bliss

Key Terms

Rule 144, restricted stock vesting, vested equity award distribution

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

FAQ

What does the Form 144 filing disclose for Teladoc Health (TDOC)?

The filing discloses that officer Kelly M. Bliss has filed a Rule 144 notice to sell 7,357 shares of Teladoc Health common stock through Fidelity Brokerage Services LLC, with an indicated aggregate market value of $46,358.67 as of September 2, 2026.

Who is selling Teladoc Health (TDOC) shares in this Form 144?

The seller is Kelly M. Bliss, identified as an officer of Teladoc Health, Inc. The notice is signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kelly M. Bliss.

How many Teladoc Health (TDOC) shares are covered by the planned Rule 144 sale?

The notice covers 7,357 shares of Teladoc Health common stock, with an indicated aggregate market value of $46,358.67 as of September 2, 2026, to be sold on the NYSE.

How were the Teladoc Health (TDOC) shares to be sold acquired?

The 7,357 shares to be sold were acquired on September 1, 2026 through restricted stock vesting, identified as compensation from the issuer, Teladoc Health, Inc.

What does the filing say about the purpose of the Teladoc (TDOC) share sale?

The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution, indicating part of the proceeds are intended to satisfy related taxes.

What Teladoc Health (TDOC) stock sales by Kelly M. Bliss occurred in the past 3 months?

Reported prior sales include 7,679 shares for $58,567.73 on June 2, 2026; 2,500 shares for $21,250.00 on June 29, 2026; 2,500 shares for $22,500.00 on July 1, 2026; and 2,500 shares for $23,750.00 on July 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:03 PM Accepted by SEC EDGAR 09/02/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002036989
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Bliss Kelly
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7357	46358.67	181684021	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Vesting	Issuer			7357	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kelly M. Bliss 155 E 44th Street Suite 1700 New York NY 10017	Common	06/02/2026	7679	58567.73
Kelly M. Bliss 155 E 44th Street Suite 1700 New York NY 10017	Common	06/29/2026	2500	21250.00
Kelly M. Bliss 155 E 44th Street Suite 1700 New York NY 10017	Common	07/01/2026	2500	22500.00
Kelly M. Bliss 155 E 44th Street Suite 1700 New York NY 10017	Common	07/06/2026	2500	23750.00

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kelly M. Bliss
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)